SCHEMBL4565600

SCHEMBL4565600

Fc1ccc(-n2cc(I)cn2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.40
SIGMAR1 Q99720 1/20 0.36
GAA P10253 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CFTR P13569 3/20 0.33
CYP17A1 P05093 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
LMNA P02545 1/20 0.33
TDO2 P48775 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALKBH1 Q13686 1/20 0.32
GLA P06280 1/20 0.32
IDH1 O75874 1/20 0.32
IDH2 P48735 1/20 0.32
SPR P35270 1/20 0.32
MAPK14 Q16539 1/20 0.32
PDK2 Q15119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27922066 0.85 P2RX7 (0.37) GAACYP17A1CYP1A2TDO2KDM4E
SCHEMBL12482331 0.81 HCAR1 (0.39) CYP17A1KDM4E
SCHEMBL23949914 0.80 CYP11B2 (0.39) CYP17A1
SCHEMBL10264757 0.79 TDO2 (0.44) ACKR3SIGMAR1NPC1RAB9ACYP17A1
SCHEMBL25514014 0.79 ACKR3 (0.40) ACKR3SIGMAR1GAANPC1RAB9A
SCHEMBL26618162 0.77 ALDH1A1 (0.47) GAANPC1RAB9AALDH1A1LMNA
SCHEMBL28805916 0.77 TDO2 (0.33) TDO2ALKBH1IDH1IDH2
SCHEMBL28803189 0.77 IDH1 (0.34) IDH1IDH2
SCHEMBL2609426 0.76 CFTR (0.43) ACKR3SIGMAR1NPC1RAB9ACFTR
SCHEMBL20162925 0.76 SCD (0.44) ACKR3SIGMAR1GAACFTRALKBH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018109271-A1 NEW BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2018-06-21 WO disclosed
WO-2018109271-A1 NEW BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2018-06-21 WO disclosed
EP-2638041-A1 SUBSTITUTED AZAINDAZOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2013-09-18 EP disclosed
EP-2593453-A1 AZAINDAZOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2013-05-22 EP disclosed
WO-2012064815-A1 SUBSTITUTED AZAINDAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-05-18 WO disclosed
WO-2012009510-A1 AZAINDAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-01-19 WO disclosed